An HIV/AIDS cure is finally coming in less than 2 years, according to medical researchers. The statement came after extensive analysis of a tree bark in Samoa which is used to make medicinal tea. This new finding will add to the two prominent HIV vaccines currently undergoing clinical trials, which will hopefully lead to the end of the HIV pandemic.
Medicinal Herb Will Cure AIDS
Within 18 to 24 months, an AIDS medicine will be made available to the public, according to Dr. Paul Wender of Stanford University. The medicine is based from a mamala tree in Samoa.
"AIDS has changed from a death sentence to now you can live with AIDS, but do I think we're in a position right now where we can ask the next question. 'Can we actually eradicate the disease? Can you lower the load efficiently, minimise exposure, and limit transmission?' Absolutely," Dr. Wender told the Healthline, quoted by TVNZ.
Dr. Wender, Paul Cox, Stephen Brown and other scientists first heard about the medicinal tree, mamala, when it was used against the viral hepatitis at the most western area of Samoa in Falealupo. The United States National Cancer Institute analysed the tree bark and recognised it to contain a key ingredient for medical purposes.
Prostratin as Key Factor
Dr. Wender was able to make his breakthrough after synthesising prostratin from the mamala tree. Prostratin appears to be very effective against AIDS, Alzheimer's disease and cancer.
Prostratin is a protein enzyme which is found in the mamala tree in Samoa and Pimelea in Australia. It possesses antiviral characteristics according to the findings of Dr. Cox and a team from the U.S. National Cancer Institute. Samoan healers use the tree to treat the viral hepatitis. When used against HIV, the treatment flushes out viral reservoirs from infected CD4+ T-cells in the immune system.
Due to its interesting ability to activate latent viral reservoirs while preventing healthy cells from being infected, several medical groups and other institutes including the Samoan government are pushing for the development of prostratin drugs designed for HIV/AIDS.
Dr. Wender's new versions of prostratin showed promising test results in animals. Prostratin is now being tested in humans with AIDS, aiming to both prevent HIV and flush out virus from infected cells.
"This is hugely exciting. We're dealing with real cells from real people who have a real problem. It's a green light," Dr. Wender said.
The Phase I human clinical trials of prostratin is carried out by the AIDS Research Alliance in Los Angeles, Calif., while the people of Samoan gains 20 percent of the profits from any drug made out of mamala tree.
To contact the editor, e-mail: